|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size 3/05/24 Axon Enterprise, Inc. 8-K:5,9 3/04/24 11:161K |
Document/Exhibit Description Pages Size 1: 8-K Current Report HTML 36K 6: R1 Document and Entity Information Document HTML 45K 8: XML IDEA XML File -- Filing Summary XML 12K 11: XML XBRL Instance -- axon-20240304x8k_htm XML 15K 7: EXCEL IDEA Workbook of Financial Report Info XLSX 8K 3: EX-101.DEF XBRL Definitions -- axon-20240304_def XML 11K 4: EX-101.LAB XBRL Labels -- axon-20240304_lab XML 61K 5: EX-101.PRE XBRL Presentations -- axon-20240304_pre XML 35K 2: EX-101.SCH XBRL Schema -- axon-20240304 XSD 15K 9: JSON XBRL Instance as JSON Data -- MetaLinks 12± 18K 10: ZIP XBRL Zipped Folder -- 0001069183-24-000015-xbrl Zip 14K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form i 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
i Axon Enterprise, Inc.
(Exact name of registrant as specified in its charter)
| | |
i Delaware | i 86-0741227 | |
(State or other jurisdiction of | (Commission File Number) | (IRS Employer |
i 17800 N. 85th St.
i Scottsdale, i Arizona i 85255
(Address of principal executive offices, including zip code)
( i 480) i 991-0797
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
Securities registered pursuant to Section 12(b) of the Act:
| | |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
i Common Stock, $0.00001 Par Value | i AXON | The i Nasdaq Global Select Market |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
i ☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
i ☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
i ☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
i ☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter). Emerging growth company i ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On March 4, 2024, the Board of Directors (the “Board”) of Axon Enterprise, Inc. (the “Company”) accepted Mark W. Kroll, Ph.D.’s resignation from the Board, effective as of the date of the Company’s 2024 Annual Meeting of Shareholders. The Board greatly appreciates Dr. Kroll’s deep commitment, leadership and many contributions to the Board and to the Company’s growth and progress during his years of service.
| | |
| | |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | | |
Dated: March 5, 2024 | Axon Enterprise, Inc. |
| |
| | | |
| By: | /s/ Isaiah Fields | |
| | | |
| | Chief Legal Officer and Corporate Secretary | |
| This ‘8-K’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 3/5/24 | None on these Dates | ||
| For Period end: | 3/4/24 | |||
| List all Filings | ||||